Towards an integrative approach to understanding the role of chemerin in human health and disease

Obesity Reviews

Volumn 14, Issue 3, 2013, Pages 245-262

  Rourke, J L ^a   Dranse, H J ^a   Sinal, C J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adipokine; Chemerin; Diabetes; Obesity

Indexed keywords

C REACTIVE PROTEIN; CHEMERIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALLERGIC ENCEPHALOMYELITIS; BROWN ADIPOSE TISSUE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CEREBROSPINAL FLUID; CHRONIC KIDNEY DISEASE; CHRONIC PANCREATITIS; CLINICAL RESEARCH; DESENSITIZATION; EX VIVO STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERTENSION; IMMUNE RESPONSE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN QUATERNARY STRUCTURE; PSORIASIS; PSORIATIC ARTHRITIS; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; ULCERATIVE COLITIS; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

CARDIOVASCULAR DISEASES; CHEMOKINES; DIABETES MELLITUS, TYPE 2; HEALTH STATUS; HOMEOSTASIS; HUMANS; INFLAMMATION; OBESITY; RECEPTORS, CHEMOKINE;

EID: 84874022871     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12009     Document Type: Review

References (116)

1. World Health Organization. Obesity and Overweight Fact sheet No311. [document] URL http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed October 2012).
2. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
3. Poulos SP, Hausman DB, Hausman GJ. The development and endocrine functions of adipose tissue. Mol Cell Endocrinol 2010; 323: 20-34.
4. Goralski KB, McCarthy TC, Hanniman EA etal. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007; 282: 28175-28188.
5. Nagpal S, Patel S, Jacobe H etal. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol 1997; 109: 91-95.
6. Bozaoglu K, Bolton K, McMillan J etal. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007; 148: 4687-4694.
7. Issa ME, Muruganandan S, Ernst MC etal. Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis. Am J Physiol Cell Physiol 2012; 302: C1621-C1631.
8. Takahashi M, Okimura Y, Iguchi G etal. Chemerin regulates beta-cell function in mice. Sci Rep 2011; 1: 123.
9. Parlee SD, Ernst MC, Muruganandan S, Sinal CJ, Goralski KB. Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}. Endocrinology 2010; 151: 2590-2602.
10. Tan BK, Chen J, Farhatullah S etal. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009; 58: 1971-1977.
11. Bozaoglu K, Segal D, Shields KA etal. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 2009; 94: 3085-3088.
12. Chakaroun R, Raschpichler M, Kloting N etal. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 2012; 61: 706-714.
13. Dong B, Ji W, Zhang Y. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 2011; 50: 1093-1097.
14. Lehrke M, Becker A, Greif M etal. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 2009; 161: 339-344.
15. Stejskal D, Karpisek M, Hanulova Z, Svestak M. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population - a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008; 152: 217-221.
16. Huang K, Du G, Li L, Liang H, Zhang B. Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis. Biomarkers 2012; 17: 16-20.
17. Weigert J, Neumeier M, Wanninger J etal. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010; 72: 342-348.
18. Yamamoto T, Qureshi AR, Anderstam B etal. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 2010; 25: 4017-4023.
19. Yang M, Yang G, Dong J etal. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J Investig Med 2010; 58: 883-886.
20. Wittamer V, Franssen JD, Vulcano M etal. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003; 198: 977-985.
21. Du XY, Zabel BA, Myles T etal. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activatable fibrinolysis inhibitor), and platelets. J Biol Chem 2009; 284: 751-758.
22. Meder W, Wendland M, Busmann A etal. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett 2003; 555: 495-499.
23. Yamaguchi Y, Du XY, Zhao L, Morser J, Leung LL. Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma. J Biol Chem 2011; 286: 39510-39519.
24. Zabel BA, Allen SJ, Kulig P etal. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005; 280: 34661-34666.
25. Zhao L, Yamaguchi Y, Sharif S etal. Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma. J Biol Chem 2011; 286: 39520-39527.
26. Guillabert A, Wittamer V, Bondue B etal. Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J Leukoc Biol 2008; 84: 1530-1538.
27. Kraakman L, Lemaire K, Ma P etal. A Saccharomyces cerevisiae G-protein coupled receptor, Gpr1, is specifically required for glucose activation of the cAMP pathway during the transition to growth on glucose. Mol Microbiol 1999; 32: 1002-1012.
28. Lorenz MC, Pan X, Harashima T etal. The G protein-coupled receptor gpr1 is a nutrient sensor that regulates pseudohyphal differentiation in Saccharomyces cerevisiae. Genetics 2000; 154: 609-622.
29. Barnea G, Strapps W, Herrada G etal. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci U S A 2008; 105: 64-69.
30. Zabel BA, Nakae S, Zuniga L etal. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008; 205: 2207-2220.
31. Muruganandan S, Roman AA, Sinal CJ. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res 2010; 25: 222-234.
32. Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell 2008; 135: 561-571.
33. Berg V, Sveinbjornsson B, Bendiksen S, Brox J, Meknas K, Figenschau Y. Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res Ther 2010; 12: R228.
34. Kaneko K, Miyabe Y, Takayasu A etal. Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res Ther 2011; 13: R158.
35. Kaur J, Adya R, Tan BK, Chen J, Randeva HS. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 2010; 391: 1762-1768.
36. Roh SG, Song SH, Choi KC etal. Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007; 362: 1013-1018.
37. Hart R, Greaves DR. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 2010; 185: 3728-3739.
38. Yamawaki H, Kameshima S, Usui T, Okada M, Hara Y. A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem Biophys Res Commun 2012; 423: 152-157.
39. Pfau D, Bachmann A, Lossner U etal. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2010; 33: 171-173.
40. Rutkowski P, Sledzinski T, Zielinska H etal. Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation. Regul Pept 2012; 173: 55-59.
41. Adrych K, Stojek M, Smoczynski M, Sledzinski T, Sylwia SW, Swierczynski J. Increased serum chemerin concentration in patients with chronic pancreatitis. Dig Liver Dis 2012; 44: 393-397.
42. Stepan H, Philipp A, Roth I etal. Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept 2011; 168: 69-72.
43. Kukla M, Zwirska-Korczala K, Gabriel A etal. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat 2010; 17: 661-667.
44. Sell H, Divoux A, Poitou C etal. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010; 95: 2892-2896.
45. Yilmaz Y, Kurt R, Gurdal A etal. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011; 217: 125-129.
46. Yilmaz Y, Yonal O, Kurt R etal. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol 2011; 46: 91-97.
47. Feng X, Li P, Zhou C, Jia X, Kang J. Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome. Biomarkers 2012; 17: 248-253.
48. Landgraf K, Friebe D, Ullrich T etal. Chemerin as a mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab 2012; 97: E556-E564.
49. Tonjes A, Fasshauer M, Kratzsch J, Stumvoll M, Bluher M. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 2010; 5: e13911.
50. De Palma G, Castellano G, Del Prete A etal. The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis. Kidney Int 2011; 79: 1228-1235.
51. Maheshwari A, Kurundkar AR, Shaik SS etal. Epithelial cells in fetal intestine produce chemerin to recruit macrophages. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1-G10.
52. Albanesi C, Scarponi C, Bosisio D, Sozzani S, Girolomoni G. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis. Autoimmunity 2010; 43: 215-219.
53. Albanesi C, Scarponi C, Pallotta S etal. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 2009; 206: 249-258.
54. Lande R, Gafa V, Serafini B etal. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J Neuropathol Exp Neurol 2008; 67: 388-401.
55. Monnier J, Lewen S, O'Hara E etal. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J Immunol 2012; 189: 956-967.
56. Pachynski RK, Zabel BA, Kohrt HE etal. The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. J Exp Med 2012; 209: 1427-1435.
57. Parolini S, Santoro A, Marcenaro E etal. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007; 109: 3625-3632.
58. Vermi W, Lonardi S, Morassi M etal. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage. Immunobiology 2009; 214: 877-886.
59. Vermi W, Riboldi E, Wittamer V etal. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 2005; 201: 509-515.
60. Eisinger K, Bauer S, Schaffler A etal. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Pathol 2012; 92: 90-96.
61. Kulig P, Zabel BA, Dubin G etal. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J Immunol 2007; 178: 3713-3720.
62. Wittamer V, Bondue B, Guillabert A, Vassart G, Parmentier M, Communi D. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 2005; 175: 487-493.
63. Graham KL, Zabel BA, Loghavi S etal. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. J Immunol 2009; 183: 6717-6723.
64. Cash JL, Hart R, Russ A etal. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008; 205: 767-775.
65. Luangsay S, Wittamer V, Bondue B etal. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol 2009; 183: 6489-6499.
66. Bondue B, Vosters O, de Nadai P etal. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. PLoS Pathog 2011; 7: e1002358.
67. Bondue B, De Henau O, Luangsay S etal. The Chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo. PLoS ONE 2012; 7: e40043.
68. Arita M, Bianchini F, Aliberti J etal. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005; 201: 713-722.
69. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007; 178: 3912-3917.
70. Ernst MC, Haidl ID, Zuniga LA etal. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 2012; 153: 672-682.
71. Ernst MC, Issa M, Goralski KB, Sinal CJ. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010; 151: 1998-2007.
72. Yoo HJ, Choi HY, Yang SJ etal. Circulating chemerin level is independently correlated with arterial stiffness. J Atheroscler Thromb 2012; 19: 59-66; discussion 67-68.
73. Shin HY, Lee DC, Chu SH etal. Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clin Endocrinol (Oxf) 2012; 77: 47-50.
74. Ress C, Tschoner A, Engl J etal. Effect of bariatric surgery on circulating chemerin levels. Eur J Clin Invest 2010; 40: 277-280.
75. Bluher M, Rudich A, Kloting N etal. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012; 35: 342-349.
76. Saremi A, Shavandi N, Parastesh M, Daneshmand H. Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men. Asian J Sports Med 2010; 1: 151-158.
77. Sell H, Laurencikiene J, Taube A etal. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009; 58: 2731-2740.
78. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010; 21: 660-667.
79. Muruganandan S, Parlee SD, Rourke JL, Ernst MC, Goralski KB, Sinal CJ. Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem 2011; 286: 23982-23995.
80. Bozaoglu K, Curran JE, Stocker CJ etal. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab 2010; 95: 2476-2485.
81. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111-2117.
82. Bauer S, Wanninger J, Schmidhofer S etal. Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology 2011; 152: 26-35.
83. Kralisch S, Weise S, Sommer G etal. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept 2009; 154: 102-106.
84. Chu SH, Lee MK, Ahn KY etal. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS ONE 2012; 7: e34710.
85. Min JL, Nicholson G, Halgrimsdottir I etal. Coexpression network analysis in abdominal and gluteal adipose tissue reveals regulatory genetic loci for metabolic syndrome and related phenotypes. PLoS Genet 2012; 8: e1002505.
86. Yan Q, Zhang Y, Hong J etal. The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 2012; 41: 281-288.
87. Hah YJ, Kim NK, Kim MK etal. Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease. Diabetes Metab J 2011; 35: 248-254.
88. Becker M, Rabe K, Lebherz C etal. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 2010; 59: 2898-2903.
89. Takahashi M, Takahashi Y, Takahashi K etal. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 2008; 582: 573-578.
90. Kloting N, Fasshauer M, Dietrich A etal. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010; 299: E506-E515.
91. Ouwens DM, Bekaert M, Lapauw B etal. Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome. Arch Physiol Biochem 2012; 118: 135-138.
92. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14: 741-751.
93. Wilson PW. Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinol Metab Clin North Am 2004; 33: 467-481.
94. Zakareia FA. Correlation of peripheral arterial blood flow with plasma chemerin and VEGF in diabetic peripheral vascular disease. Biomark Med 2012; 6: 81-87.
95. Xiaotao L, Xiaoxia Z, Yue X, Liye W. Serum chemerin levels are associated with the presence and extent of coronary artery disease. Coron Artery Dis 2012; 23: 412-416.
96. Gao X, Mi S, Zhang F etal. Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovasc Diabetol 2011; 10: 87.
97. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 2010; 17: 115-130.
98. Ren RZ, Zhang X, Xu J etal. Chronic ethanol consumption increases the levels of chemerin in the serum and adipose tissue of humans and rats. Acta Pharmacol Sin 2012; 33: 652-659.
99. Alfadda AA, Sallam RM, Chishti MA etal. Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism. Mol Cells 2012; 33: 591-596.
100. Shimamura K, Matsuda M, Miyamoto Y, Yoshimoto R, Seo T, Tokita S. Identification of a stable chemerin analog with potent activity toward ChemR23. Peptides 2009; 30: 1529-1538.
101. Hu W, Yu Q, Zhang J, Liu D. Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats. Inflammation 2012; 35: 1287-1293.
102. Pei L, Yang J, Du J, Liu H, Ao N, Zhang Y. Downregulation of chemerin and alleviation of endoplasmic reticulum stress by metformin in adipose tissue of rats. Diabetes Res Clin Pract 2012; 97: 267-275.
103. Zabel BA, Silverio AM, Butcher EC. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 2005; 174: 244-251.
104. Lin W, Chen YL, Jiang L, Chen JK. Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma. Clin Lab 2011; 57: 879-885.
105. Zheng Y, Luo S, Wang G etal. Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma. Eur J Dermatol 2008; 18: 638-641.
106. Garces MF, Sanchez E, Acosta BJ etal. Expression and regulation of chemerin during rat pregnancy. Placenta 2012; 33: 373-378.
107. Rama D, Esendagli G, Guc D. Expression of chemokine-like receptor 1 (CMKLR1) on J744A.1 macrophages co-cultured with fibroblast and/or tumor cells: modeling the influence of microenvironment. Cell Immunol 2011; 271: 134-140.
108. Stables J, Green A, Marshall F etal. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem 1997; 252: 115-126.
109. Kulig P, Kantyka T, Zabel BA etal. Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. J Immunol 2011; 187: 1403-1410.
110. Nakajima H, Nakajima K, Nagano Y etal. Circulating level of chemerin is upregulated in psoriasis. J Dermatol Sci 2010; 60: 45-47.
111. Hu W, Feng P. Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract 2011; 91: 159-163.
112. Pfau D, Stepan H, Kratzsch J etal. Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr 2010; 74: 56-61.
113. Verrijn Stuart AA, Schipper HS, Tasdelen I etal. Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. J Clin Endocrinol Metab 2012; 97: 463-472.
114. Kukla M, Mazur W, Buldak RJ, Zwirska-Korczala K. Potential role of leptin, adiponectin and three novel adipokines - visfatin, chemerin and vaspin - in chronic hepatitis. Mol Med 2011; 17: 1397-1410.
115. Duan DM, Niu JM, Lei Q, Lin XH, Chen X. Serum levels of the adipokine chemerin in preeclampsia. J Perinat Med 2011; 40: 121-127.
116. Weigert J, Obermeier F, Neumeier M etal. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis 2010; 16: 630-637.